Plieskatt J - Search Results

1

Development and Qualification of an Antigen Integrity Assay for a Plasmodium falciparum Malaria Transmission Blocking Vaccine Candidate, Pfs230.

Miura K, Pham TP, Lee SM, Plieskatt J, Diouf A, Sagara I, Coelho CH, Duffy PE, Wu Y, Long CA. Miura K, et al. Among authors: plieskatt j. Vaccines (Basel). 2022 Sep 28;10(10):1628. doi: 10.3390/vaccines10101628. Vaccines (Basel). 2022. PMID: 36298492 Free PMC article.

2

Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.

Lee SM, Wu CK, Plieskatt J, McAdams DH, Miura K, Ockenhouse C, King CR. Lee SM, et al. Among authors: plieskatt j. Malar J. 2016 Aug 11;15(1):405. doi: 10.1186/s12936-016-1464-6. Malar J. 2016. PMID: 27515826 Free PMC article.

3

N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate.

Lee SM, Wu CK, Plieskatt JL, Miura K, Hickey JM, King CR. Lee SM, et al. Clin Vaccine Immunol. 2017 Oct 5;24(10):e00140-17. doi: 10.1128/CVI.00140-17. Print 2017 Oct. Clin Vaccine Immunol. 2017. PMID: 28747311 Free PMC article.

4

Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate.

Lee SM, Plieskatt J, King CR. Lee SM, et al. Among authors: plieskatt j. Anal Biochem. 2018 Feb 1;542:20-23. doi: 10.1016/j.ab.2017.11.009. Epub 2017 Nov 21. Anal Biochem. 2018. PMID: 29162427 Free PMC article.

5

Peptide data on the disulfide bond analysis of baculovirus produced Pfs25 by LC-MSMS.

Lee SM, Plieskatt JL, King CR. Lee SM, et al. Data Brief. 2018 Mar 12;18:209-233. doi: 10.1016/j.dib.2018.03.034. eCollection 2018 Jun. Data Brief. 2018. PMID: 29896512 Free PMC article.

6

ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.

Miura K, Deng B, Wu Y, Zhou L, Pham TP, Diouf A, Wu CK, Lee SM, Plieskatt JL, Morin MJ, Long CA. Miura K, et al. Among authors: plieskatt jl. Vaccine. 2019 Apr 3;37(15):2073-2078. doi: 10.1016/j.vaccine.2019.02.071. Epub 2019 Mar 5. Vaccine. 2019. PMID: 30850239 Free PMC article.

7

Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate.

Lee SM, Plieskatt J, Krishnan S, Raina M, Harishchandra R, King CR. Lee SM, et al. Among authors: plieskatt j. Protein Expr Purif. 2019 Aug;160:56-65. doi: 10.1016/j.pep.2019.04.001. Epub 2019 Apr 10. Protein Expr Purif. 2019. PMID: 30978392 Free PMC article.

8

The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate.

Lee SM, Wu Y, Hickey JM, Miura K, Whitaker N, Joshi SB, Volkin DB, Richter King C, Plieskatt J. Lee SM, et al. Among authors: plieskatt j. Malar J. 2019 Nov 8;18(1):356. doi: 10.1186/s12936-019-2989-2. Malar J. 2019. PMID: 31703583 Free PMC article.

9

A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system.

Lee SM, Hickey JM, Miura K, Joshi SB, Volkin DB, King CR, Plieskatt JL. Lee SM, et al. Sci Rep. 2020 Jan 15;10(1):395. doi: 10.1038/s41598-019-57384-w. Sci Rep. 2020. PMID: 31942034 Free PMC article.

10

Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.

Singh SK, Plieskatt J, Chourasia BK, Singh V, Bengtsson KL, Reimer JM, van Daalen RC, Teelen K, van de Vegte-Bolmer M, van Gemert GJ, Jore MM, Theisen M. Singh SK, et al. Among authors: plieskatt j. NPJ Vaccines. 2021 Oct 12;6(1):120. doi: 10.1038/s41541-021-00383-8. NPJ Vaccines. 2021. PMID: 34642303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters